The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death

Cancer

Volumn 115, Issue 21, 2009, Pages 5071-5083

  Chen, L Leon ^a   Nolan, Matthew E ^a   Silverstein, Melvin J ^b   Mihm Jr , Martin C ^a,c   Sober, Arthur J ^a,c   Tanabe, Kenneth K ^a,c   Smith, Barbara L ^a,c   Younger, Jerry ^a,c   Michaelson, James S ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Cancer death; Lymph node status; Melanoma; Prediction; Prognostic factors; Risk; Tumor size

Indexed keywords

ADENOCARCINOMA; ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER MORTALITY; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATORY DISEASE; LETHALITY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; MELANOMA; MUCINOUS CARCINOMA; PAGET NIPPLE DISEASE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCIRRHOUS ADENOCARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; TUMOR BURDEN;

EID: 70350503158     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24565     Document Type: Article

References (17)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187. (Pubitemid 19032001)
2. Michaelson JS, Silverstein M, Wyatt J, et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer. 2002;95:713-723. (Pubitemid 34839661)
3. Michaelson JS, Silverstein M, Sgroi D, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer. 2003;98:2133-2143. (Pubitemid 37392416)
4. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow- up. Histopathology. 1991;19:403-410.
5. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol. 1999;17:1442-1448. (Pubitemid 29220850)
6. Wong SL, Chao C, Edwards MJ, et al. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am J Surg. 2002;184:492-498. (Pubitemid 35477702)
7. Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986;315:559-563. (Pubitemid 16052469)
8. Subramaniam DS, Isaacs C. Utilizing prognostic and predictive factors in breast cancer. Curr Treat Options Oncol. 2005;6:147-159. (Pubitemid 40392701)
9. Hermanek P. Prognostic factor research in oncology. J Clin Epidemiol. 1999;52:371-374.
10. Michaelson JS, Chen LL, Silverstein MJ, et al. How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death. Cancer. 2009;115:000-000
11. Ries DAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, Md: National Cancer Institute; 2008.
12. Michaelson JS, Chen LL, Silverstein MJ, et al. Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death. Cancer. 2009;115:000-000
13. West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A. 2001;98:11462-11467. (Pubitemid 32928751)
14. Van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-536.
15. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001;19:980-991. (Pubitemid 32176272)
16. Michaelson J. The role of molecular discreteness in normal and cancerous growth. Anticancer Res. 1999;19:4853-4867. (Pubitemid 30093494)
17. Michaelson JS, Cheongsiatmoy JA, Dewey F, et al. Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism. Br J Cancer. 2005;93:1244-1249. (Pubitemid 41679410)